Back to Search
Start Over
Comparison of clinical features and outcomes between HBV-related and non-B non-C hepatocellular carcinoma
- Source :
- Infectious Agents and Cancer, Vol 15, Iss 1, Pp 1-6 (2020), Infectious Agents and Cancer
- Publication Year :
- 2020
- Publisher :
- BMC, 2020.
-
Abstract
- Objective To evaluate the difference between hepatitis B virus related hepatocellular carcinoma (HBV-HCC) and non-HBV non-HCV hepatocellular carcinoma (NBNC-HCC) patients based on clinical features and prognosis. Methods A total of 175 patients with HCC were enrolled. Patients’ characteristics were extracted from medical records. Among them, 107 patients were positive for HBsAg and negative for HCV-Ab while 68 patients were negative for HBsAg and HCV-Ab. Results The patients in the NBNC-HCC group were significantly older than those in the HBV-HCC group (P = 0.045). Moreover, vascular invasion was found in 23.4% of HBV-HCC patients, which was significantly higher than that in the NBNC-HCC patients with 10.3% (P = 0.029). Kaplan-Meier analysis revealed that HBV-HCC patients had significantly worse outcomes in terms of overall survival (P = 0.036). Compared with the NBNC-HCC patients, the HBV-HCC patients had a significantly worse disease-free survival (P = 0.0018). The multivariate analysis results indicated that TNM stage (HR = 1.541, 95%CI 1.072–2.412, P = 0.002) and HBV infection (HR = 1.087, 95%CI 1.012–1.655, P = 0.042) were independent risk variables for overall survival. While vascular invasion (HR = 1.562, 95%CI 1.013–2.815, P = 0.042) and HBV infection (HR = 1.650, 95%CI 1.017–2.676, P = 0.037) were independent risk factors associated with disease-free survival. Conclusion Our data revealed that HBV-HCC is more common in young males with vascular invasion, while NBNC-HCC occurs mostly in elderly patients, and overall survival rate is significantly better than that of HBV-HCC. Our study therefore provides evidence that patients with HBV-HCC require closer follow-up due to their poor prognosis.
- Subjects :
- Cancer Research
medicine.medical_specialty
HBsAg
Poor prognosis
Hepatitis B virus
Multivariate analysis
Epidemiology
Hepatocellular carcinoma
medicine.disease_cause
Gastroenterology
lcsh:RC254-282
lcsh:Infectious and parasitic diseases
03 medical and health sciences
0302 clinical medicine
Internal medicine
medicine
lcsh:RC109-216
Stage (cooking)
neoplasms
business.industry
Medical record
virus diseases
Biomarker
medicine.disease
Prognosis
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
digestive system diseases
Infectious Diseases
Oncology
030220 oncology & carcinogenesis
Biomarker (medicine)
030211 gastroenterology & hepatology
business
Research Article
Subjects
Details
- Language :
- English
- ISSN :
- 17509378
- Volume :
- 15
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Infectious Agents and Cancer
- Accession number :
- edsair.doi.dedup.....e4b51bc45188844d475ae94e45bb0018